Skip to main content
. 2021 Apr 1;16:2597–2613. doi: 10.2147/IJN.S295445

Figure 3.

Figure 3

The inhibitory ability of SNO-HSA-PTX on platelets. (A) Aggregation images of CFSE-labeled platelets treated with HSA-PTX, HSA-PTX+US, SNO-HSA-PTX or HSA-PTX+US (1 MHz, 2 W/cm2, 5 min). Scale bar = 50 μm. (B) The aggregation rates of platelets with different treatments induced by thrombin. ***p < 0.001. (C) ATP release from platelets activated by thrombin. *p < 0.05. (D) Representative image of platelet adhesion. Scale bar: 50 μm. (E) Quantification of platelet adhesion after treatment with HSA-PTX, HSA-PTX+US, SNO-HSA-PTX or HSA-PTX+US (1 MHz, 2 W/cm2, 5 min). ***p < 0.001.